MedTrace Logo

Safety and Efficacy Study of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine

NCT01916278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-08-25

No results posted yet for this study

Summary

A 12-month, randomised, evaluator-blinded, comparative, multicentre study of the safety and efficacy of lip injections with Emervel Lips Lidocaine and Juvéderm Volbella with Lidocaine.

Conditions

  • Lip Filler Injections

Interventions

DEVICE

Emervel Lips Lidocaine

DEVICE

Juvéderma Volbella with Lidocaine

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Germany
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01916278 on ClinicalTrials.gov